$Aerpio Pharmaceuticals Inc(ARPO)$no bad news from the meeting. In fact, the potential NDA approval from the FDA in the coming months might set ARPO up for a HUGE run. Havingpassed trial 1 & 2 is no easy task. But ARPO has already done so with its groundbreaking FYARRO technology which can potentially help with cancer and many other diseases, so the potential is limitless!
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
